![Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial - ScienceDirect Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820309626-gr2.jpg)
Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial - ScienceDirect
![Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... | Download Scientific Diagram Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... | Download Scientific Diagram](https://www.researchgate.net/publication/352666563/figure/fig1/AS:1037755568099328@1624431616011/Flow-chart-ACS-acute-coronary-syndrome-LST-late-stent-thrombosis-VLST-very-late.png)
Flow chart. ACS, acute coronary syndrome; LST, late stent thrombosis;... | Download Scientific Diagram
![Acute coronary syndrome due to very late stent thrombosis 3 years after... | Download Scientific Diagram Acute coronary syndrome due to very late stent thrombosis 3 years after... | Download Scientific Diagram](https://www.researchgate.net/publication/341406287/figure/fig1/AS:891462946402306@1589552737385/Acute-coronary-syndrome-due-to-very-late-stent-thrombosis-3-years-after-ostial-stenting.png)
Acute coronary syndrome due to very late stent thrombosis 3 years after... | Download Scientific Diagram
![JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome](https://pub.mdpi-res.com/jcm/jcm-11-04018/article_deploy/html/images/jcm-11-04018-g001.png?1657589303)
JCM | Free Full-Text | Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome
![Causes of Early Stent Thrombosis in Patients Presenting With Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study - ScienceDirect Causes of Early Stent Thrombosis in Patients Presenting With Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109714020105-gr1.jpg)
Causes of Early Stent Thrombosis in Patients Presenting With Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study - ScienceDirect
![Prasugrel better than clopidogrel in reducing intra-stent tissue in ACS patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Prasugrel better than clopidogrel in reducing intra-stent tissue in ACS patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/F660F04D-2FF0-4AD8-9A07-A7BE00E267D1/OriginalThumbnail/THUMBNAIL_shutterstock_643296895.jpg)
Prasugrel better than clopidogrel in reducing intra-stent tissue in ACS patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![COMBO Stent Demonstrates High Procedural Success and Low Revascularization Rates - The Cardiology Advisor COMBO Stent Demonstrates High Procedural Success and Low Revascularization Rates - The Cardiology Advisor](https://www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/01/achillesarteriallesionsstents_894227.jpg)
COMBO Stent Demonstrates High Procedural Success and Low Revascularization Rates - The Cardiology Advisor
Interface Engineering of Fully Metallic Stents Enabling Controllable H2O2 Generation for Antirestenosis | Langmuir
![Figure 50, Relative Risk of Definite or Probable Stent Thrombosis by Acute Coronary Syndrome Status - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration - Figure 50, Relative Risk of Definite or Probable Stent Thrombosis by Acute Coronary Syndrome Status - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration -](https://www.ncbi.nlm.nih.gov/books/NBK542926/bin/ch6f50.jpg)
Figure 50, Relative Risk of Definite or Probable Stent Thrombosis by Acute Coronary Syndrome Status - Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration -
![Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis | The BMJ Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis | The BMJ](https://www.bmj.com/content/bmj/365/bmj.l2222/F4.medium.jpg)
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis | The BMJ
![Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents | SCAI Duration of Dual Anti-Platelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents | SCAI](https://scai.org/sites/default/files/2020-12/March2017_Figure1_QIT.png)